
Dan Switzer
Head of US Oncology Business Division
Daiichi Sankyo
Pharmaceutical executive with strong background in General Management and Board-level leadership. Proven track record of leading successful teams and nurturing talent. History of combining leadership, analytical, and marketing skills to drive sales and profit. Extensive launch experience and co-promote/alliance leadership; broad therapeutic expertise including oncology and ADCs. Demonstrated ability to create a positive and dynamic organizational culture emphasizing collaboration, innovation, and high employee engagement. Currently lead DSI US Oncology Business Division.
Speaking In
-
16-Jun-2025